IP Group

Touchstone Innovations is a venture capital firm that focuses on creating, building, and investing in pioneering technology companies emerging from exceptional scientific research in the 'Golden Triangle' of London, Cambridge, and Oxford. Established in 1986, the firm employs a comprehensive strategy that encompasses the entire process from idea generation to intellectual property protection, company formation, seed funding, incubation, and scale-up. By providing continuous investment from start-up to scale-up, Touchstone Innovations supports scientists and entrepreneurs in commercializing their ideas through licensing and recruitment of top management teams. The firm has a proven track record of leveraging early-stage research into high-quality, well-managed businesses, maintaining active involvement with its portfolio companies throughout their lifecycle. With a commitment to de-risking investment, Touchstone Innovations has facilitated over £1.5 billion in funding to drive technological innovation in the UK. In 2017, the firm was acquired by IP Group plc, further expanding its capabilities in the investment landscape.

Fusion IP owns the rights to 100% of university-owned research generated at two of the UK's leading universities - The University of Sheffield and Cardiff University. These exclusive partnerships enable us to develop some of the world's most advanced and exciting science, in fields as varied as clean energy, electronics, engineering and medicine; turning world class research into valuable businesses through the creation of portfolio of companies.

Ubiquigent Limited is a biotechnology company based in Dundee, United Kingdom, founded in 2009. It specializes in the development and supply of high-quality reagents, kits, and drug discovery assay development services, primarily targeting the life science research community. Ubiquigent focuses on protein degradation and the ubiquitin signaling systems, providing services that support drug discovery efforts aimed at developing novel deubiquitylase (DUB) enzyme inhibitors. The company works closely with academic researchers and pharmaceutical scientists, aiding in the exploration of therapeutic applications for DUB modulators in areas with significant unmet medical needs. Ubiquigent is committed to generating intellectual property through its innovative drug discovery programs, which include optimizing compounds that target the ubiquitin cascade.

CrowdIPR LTD. owns and operates an online crowd-sourced intellectual property research platform. It enables startups and other enterprises to evaluate the novelty of their new product ideas; investors to determine the uniqueness of their potential investment projects; research and development intensive companies, engineers, designers, scientists, inventors, and other authors to map relevant solutions in their technology domain; patent applicants and patent attorneys to prepare patent applications of higher quality; patent owners to monitor potential competitors and patent infringers; and to collect evidences for third party observations.

Deltasight is a data company that develops a data platform for analyzing, visualizing, and predicting global innovation and IP. It offers practical and easy-to-use tools for global innovation and intellectual property analysis and visualization. The said platform generally collects data from 90 countries. Its products visually map trends and connections between companies, people, and inventions, giving businesses, R&D and technology transfer professionals a better understanding of global innovation. Its platform builds upon Deltasight’s proprietary Innovation Graph, which provides easy exploration of Innovation Profiles for inventions, people, organizations, and sectors. Its main customers include: private equity firms, technology companies, IP firms, and universities. Deltasight was founded in 2011 and is headquartered in Newcastle Upon Tyne. It is currently in private beta.

Deltasight is a data company that develops a data platform for analyzing, visualizing, and predicting global innovation and IP. It offers practical and easy-to-use tools for global innovation and intellectual property analysis and visualization. The said platform generally collects data from 90 countries. Its products visually map trends and connections between companies, people, and inventions, giving businesses, R&D and technology transfer professionals a better understanding of global innovation. Its platform builds upon Deltasight’s proprietary Innovation Graph, which provides easy exploration of Innovation Profiles for inventions, people, organizations, and sectors. Its main customers include: private equity firms, technology companies, IP firms, and universities. Deltasight was founded in 2011 and is headquartered in Newcastle Upon Tyne. It is currently in private beta.

CrowdIPR LTD. owns and operates an online crowd-sourced intellectual property research platform. It enables startups and other enterprises to evaluate the novelty of their new product ideas; investors to determine the uniqueness of their potential investment projects; research and development intensive companies, engineers, designers, scientists, inventors, and other authors to map relevant solutions in their technology domain; patent applicants and patent attorneys to prepare patent applications of higher quality; patent owners to monitor potential competitors and patent infringers; and to collect evidences for third party observations.

CrowdIPR LTD. owns and operates an online crowd-sourced intellectual property research platform. It enables startups and other enterprises to evaluate the novelty of their new product ideas; investors to determine the uniqueness of their potential investment projects; research and development intensive companies, engineers, designers, scientists, inventors, and other authors to map relevant solutions in their technology domain; patent applicants and patent attorneys to prepare patent applications of higher quality; patent owners to monitor potential competitors and patent infringers; and to collect evidences for third party observations.